Category Archives: Research

Tempus Labs Recieves Unicorn Funding Thanks To Co-Founder Eric Lefkofsky

Tempus Labs, a Chicago based company for the last two years has been working their hardest to use machine learning and other techniques to really fully understand every aspect of a cancer patients tumor. Using these techniques can help to personalize treatment for each patient to best fit their needs when it comes to their tumor and where it is located. Tempus works with many different cancer-fighting groups such as the University of Chicago, Mayo Clinic, and many other groups to help them get farther with their research and learn more information about helping their patients with their treatment plans.

Recently Tempus Labs has raised $80 million in unicorn funding to help them in their mission to help patients and their families when it comes to personalizing treatment plans more specifically based on one’s tumor. Tempus Lab’s mission is to take care of their patients and their loved ones and accommodate their needs more than most of the other cancer technology research companies out there do. The first thing on the employees of Tempus Lab’s minds is how they can best help out a patient.

Tempus Labs has a huge growing team of over 4,000 employees and grows by about 30 new employees each month. With the help of more funding, Tempus Labs is hoping to grow the number of employees hired over time to more than 30 a month. Tempus Labs would not be where it is today without the help of Co-founder Eric Lefkofsky. Eric Lefkofsky makes it his mission to make sure that everything runs smoothly at Tempus Labs and to help in the process of battling cancer as much as possible. Eric Lefkofsky is a co-founder of Tempus Labs for many reasons but his main two reasons are that he has first-hand experience with a loved one undergoing cancer treatments and he also believes that it is important to improve cancer treatments and their effectiveness.

Tempus Labs will continue its mission to make a difference in patients lives when it comes to their cancer treatment plans and will also work hard to make the experience better for those who may have cancer in the future.

To Know More Click Here

Tony Petrello: Leader In Cutting Edge Oil Drilling Technology At Nabors Industries

With oil being one of the top commodities always in demand, companies are always striving to find new ways to speed up the drilling, pipeline delivery and shipping process. There never is any room to fall behind in it, and one of the world’s leading drilling contractors is Nabors Industries, a publicly-traded company based in Houston. Their success in drilling innovation and always being in the lead when it comes to strategic partnerships is because Tony Petrello has used his great acumen while serving as Chief Executive Officer. Petrello is always in the know with the company’s research and development teams, and he has the ability to solve problems and find solid agreements when it comes to closing deals.

Tony Petrello oversees the deployment of some of the largest rig systems both in land-based operations and on offshore modules. Nabors’ holdings include the M-800 and M-1000 automated rigs with advanced analytics software and drilling data gathering. They’ve also made a big acquisition which has benefited stockholders with Tesco, and there’ll be a lot more production coming as part of their upcoming partnership with Saudi Aramco. Petrello has always had a high annual base salary, but in 2013 when a new compromise with shareholders saw a contract restructuring, his total compensation reached $68 million, the highest any CEO received that year.

Tony Petrello made his connections to get where he is today at Nabors Industries through an outstanding job as a lawyer who represented the company among other clients at Baker & McKenzie. His law practice was preceded by studying advanced math for several years at Yale University. Most of his fellow students there thought he would become a professional mathematician, but something about corporate and finance law caught his interest, so he got his JD at Harvard and spent 13 years in the field. Petrello had become managing partner of Baker & McKenzie before leaving for Nabors Industries.

Tony Petrello is perhaps even more dedicated to philanthropy as he is his career. His life was changed when his daughter Carena was born because she had a rare brain problem that has affected her life permanently. She has cerebral palsy and Tony and his wife Cynthia have gone through difficult times accepting that she won’t have the same privileges other children have had. But they both love Carena and they both decided they could take their hardship and turn it into passion to do good. That passion is giving to the Texas Children’s Hospital where professionals at a neurological research center are at work possibly finding a cure for cerebral palsy at this very moment. Petrello has given TCH’s health foundation $7 million.

To Learn More Click Here

Shervin Pishevar-One Man, Many Roles

Shervin Pishevar is a unique combination of an outstanding investor and researcher. His vision led to the formation of Hyperloop Technologies. Shervin Pishevar occupies the position of Executive Chairman at this firm, which he helped initiate. He also helped set up Sherpa Global and functions as Chief Executive Officer there. He has a vast array of experience at several companies. Mr. Peshevar has served in various capacities at Menlo Ventures since 2011. He has been the co-creator of many organizations such as Social Gaming Network Inc Seges Capital, Hotprints Limited, Webs Inc., Application Corporation and WebOS. His work at lonside Interactive was also significant where he had multiple responsibilities.

Shervin Pishevar graduated in interdisciplinary studies from the University of California. He is a keen learner and pursued further education in the form of Health Economics and Molecular Cellular Biology at the same institute in Berkeley. He has been a respected fellow at institutes such as the National Institutes of Health, M.D. Andersen Cancer Research Center and the University of California. He is also the distinguished member of several boards such as Machine Zone Inc., Blackjet Inc., Getaround Inc., and Social Programming Network, to name a few. Shervin Peshevar retains connections with several firms such as Medialets Inc., TaskRabbit Ic., Fotomoto Inc., Backupify Inc., Uber Tchnologies Inc., CarSavvy Inc. and Blackjet.

Shervin Pishevar has been the recipient of several accolades. These include the New York Times Advertising Design Award Finalist, Top Five Web Applications, 2002 Top 100 Technology Award. He also has the rare distinction of being selected for the Outstanding American by Choice by the United States administration. Recently, he received the Ellis Island Medal of Honour. He is part of the Global Entrepreneurs Council of the United Nations.

Shervin Pishevar has featured on television for his expert opinions. The Fox News and CNBC networks have interviewed him on various internet issues in the past. He has co-published a paper in the Journal of American Medical Association, which is one of the foremost medical research journals. He has also contributed to the field of malaria research. Shervin Pishevar’s exemplary work over the years has established him as a leading investor and advisor.

Visit More :


Science Discovers a Real-Life Fountain of Youth (Maybe)

The aging process has tried to be defied since the beginning of humankind. Today, there are more “anti-aging” products on the shelves than ever before. But the problem with all of the anti-aging technology is, it only covers up the aging process at best.

Science is on the edge of a break through for age stopping technology, that actually works. Researchers have been working hard, seemingly with much success, at breathing new life into cells by eliminating cells that have stopped dividing so new, replicating cells can take their place. If this process works, it would effectively end the aging process and allow a person to live indefinitely. Of course, this person would still be susceptible to death from other causes, but old age would never be one of them.

Lead researcher Crystal Hunt suggested the chances of developing this fountain are as high as 80%. However, these are grandiose claims and realistically, this technology as yet to be successful, even in mice. Only time will tell if this path to timelessness is on our horizon.